Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,639 | 247 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $801.22 | 73 | $0 (2024) |
| Lilly USA, LLC | $548.44 | 34 | $0 (2024) |
| Novo Nordisk Inc | $540.79 | 41 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $262.03 | 8 | $0 (2024) |
| Axsome Therapeutics, Inc. | $257.17 | 14 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $186.36 | 6 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $161.25 | 11 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $128.69 | 9 | $0 (2024) |
| Amgen Inc. | $107.02 | 8 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $66.14 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,430 | 74 | Axsome Therapeutics, Inc. ($257.17) |
| 2023 | $781.32 | 61 | ABBVIE INC. ($240.91) |
| 2022 | $904.80 | 68 | ABBVIE INC. ($260.14) |
| 2021 | $523.54 | 44 | AbbVie Inc. ($148.21) |
All Payment Transactions
247 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Gastroenterology | ||||||
| 12/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $1.86 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: Biological | ||||||
| 11/14/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/12/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $110.42 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: Respiratory | ||||||
| 10/31/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: Gastroenterology | ||||||
| 10/23/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/17/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.85 | General |
| Category: PSYCHIATRY | ||||||
| 10/15/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: PSYCHIATRY | ||||||
| 10/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Obesity | ||||||
| 09/25/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Diabetes | ||||||
| 09/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $100.14 | General |
| Category: PSYCHIATRY | ||||||
| 09/19/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Psychology/Psychiatric | ||||||
| 09/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 458 | 551 | $96,488 | $34,058 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 123 | 123 | $35,670 | $14,369 | 40.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 119 | 205 | $43,050 | $12,163 | 28.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 27 | 27 | $2,700 | $1,939 | 71.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 18 | 22 | $6,248 | $1,843 | 29.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 79 | 79 | $3,318 | $1,341 | 40.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 30 | 30 | $1,101 | $986.10 | 89.6% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 12 | 12 | $2,640 | $780.84 | 29.6% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 11 | 11 | $1,287 | $417.67 | 32.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 15 | 15 | $285.00 | $126.00 | 44.2% |
| 81002 | Urinalysis, manual test | Office | 2023 | 24 | 27 | $189.00 | $92.07 | 48.7% |
About Lydia Grebe, APN
Lydia Grebe, APN is a Family healthcare provider based in Columbus, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780788729.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lydia Grebe, APN has received a total of $3,639 in payments from pharmaceutical and medical device companies, with $1,430 received in 2024. These payments were reported across 247 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($3,639).
As a Medicare-enrolled provider, Grebe has provided services to 458 Medicare beneficiaries, totaling 551 services with total Medicare billing of $34,058. Data is available for 1 year (2023–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Columbus, NJ
- Active Since 09/11/2006
- Last Updated 12/19/2022
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1780788729
Products in Payments
- VRAYLAR (Drug) $700.21
- MOUNJARO (Drug) $323.38
- Auvelity (Drug) $257.17
- Ozempic (Drug) $231.27
- CAPLYTA (Drug) $199.52
- Rybelsus (Drug) $178.97
- XIFAXAN (Drug) $161.25
- BREZTRI (Drug) $138.94
- TRINTELLIX (Drug) $128.69
- Wegovy (Drug) $123.21
- TRULICITY (Drug) $120.88
- REXULTI (Drug) $99.98
- EVENITY (Biological) $94.05
- AIRSUPRA (Drug) $80.24
- NURTEC ODT (Drug) $69.64
- ZEPBOUND (Drug) $62.21
- QULIPTA (Drug) $52.33
- UBRELVY (Drug) $48.68
- FARXIGA (Drug) $42.85
- AJOVY (Biological) $41.77
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Columbus
Teresa Miller, Cnp, CNP
Family — Payments: $26,526
Beth Loessin
Family — Payments: $17,544
Eileen Faulds, Aprncnp, APRNCNP
Family — Payments: $13,709
Tarsicio Gacheru, Cnp, CNP
Family — Payments: $13,480
Toni Seibert, Apn, APN
Family — Payments: $13,241
Mary Hurley, Np-C, NP-C
Family — Payments: $11,853